Related News ItemsThis Week in Experimental and Molecular PathologyThu, 09 Feb 2012 10:48:33 -0800
In Experimental and Molecular Pathology , a team at the Kumamoto Medical Center in Japan examines the role of minichromosome maintenance protein 2 in myelodysplastic syndromes.
Read More... This Week in Modern PathologyTue, 07 Feb 2012 14:18:23 -0800
In Modern Pathology this week, researchers from the Seoul National University in South Korea report on the association between the patterns of promoter CpG island methylation of breast cancer subtypes and cancer stem cell phenotypes.
Read More... Dietary Supplement Maker Doctor’s Best, Inc., Appoints Dr. Parris M. Kidd as Chief Scientific OfficerWed, 08 Feb 2012 06:00:00 -0800
Doctor’s Best, Inc., a leading manufacturer and distributor of clinically-formulated dietary supplements, announced that dietary supplement industry researcher, product developer and educator Parris M.
Read More... Genetic Rosetta Stone unveiled in NatureWed, 08 Feb 2012 10:16:35 -0800
Scientists have developed a new community resource that may act as a Rosetta stone for revealing the genetic basis of traits and disease.
Read More... College graduates, Jan. 30, 2012Sun, 29 Jan 2012 16:38:46 -0800
GEORGIA SOUTHWESTERN STATE UNIVERSITYNatasha Jackson, Clarks Summit, bachelor of business administration in management.MISERICORDIA UNIVERSITYEsther Anelli, Lake Ariel, education, master of science; Sara Bielski, Scranton, health care management, bach
Read More... Gardasil Study Funded by Merck: Are Results Biased?; CBCD Raises DoubtsWed, 08 Feb 2012 00:12:34 -0800
This study was funded by Merck, the manufacturer of Gardasil. Many scientific papers argue that the public should not trust any industry funded research.Rochester, NY (PRWEB) February 08, 2012 The Center for the Biology of Chronic Disease (CBCD) has learned that Merck recently funded a study conducted by Dr. Chun Chao from Kaiser Permanente. USA Today reported: “Study: No link between HPV ...
Read More... This Week in the Journal of Clinical PathologyWed, 01 Feb 2012 15:18:23 -0800
Salvatore Piscuoglio from University Hospital of Basel, in Switzerland and his colleagues report in the Journal of Clinical Pathology that the loss of EpCAM expression — EpCAM is thought to be a cancer stem cell protein marker — may be linked to more aggressive tumor phenotypes in ampullary carcinomas.
Read More... MassBay Community College Participates in Cutting Edge Research With Area Schools Leading to Early Alzhiemers DetectionTue, 24 Jan 2012 08:04:21 -0800
WELLESLEY HILLS, Mass. -- Scientists from MassBay Community College successfully collaborated with biological science counterparts from University of Massachusetts-Lowell and Boston University on experiments ...
Read More... Health Discovery Corporation and Doctors Optimal Formula Launching Retinalyze Analytics for Detection of Macular ...Fri, 10 Feb 2012 05:30:00 -0800
Health Discovery Corporation , a molecular diagnostics leader in the use of patent protected advanced mathematical techniques and pattern recognition technology for personalized medicine, and Doctors Optimal Formula LLC, a physician exclusive anti-aging, health and wellness company are launching Retinalyze Analytics, to assist Ophthalmologists and Optometrists with the Detection of Macular ...
Read More... The Inaugural German Science Day - Fight CancerThu, 26 Jan 2012 03:00:20 -0800
The Inaugural German Science Day - Fight Cancer DGAP-News: MC Services AG / Key word(s): Miscellaneous The Inaugural German Science Day - Fight Cancer 26.01.2012 / 11:45 -----------------...
Read More...
| 
Top Links
